These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

905 related items for PubMed ID: 2298028

  • 1. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A, Talal N.
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [Abstract] [Full Text] [Related]

  • 2. The management of collagen diseases.
    Calin A.
    Ration Drug Ther; 1980 Jan; 14(1):1-5. PubMed ID: 7384531
    [No Abstract] [Full Text] [Related]

  • 3. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL, Shtutman VZ, Nasonova VA.
    Klin Med (Mosk); 1994 Jan; 72(5):12-9. PubMed ID: 7853807
    [No Abstract] [Full Text] [Related]

  • 4. [The treatment of collagen diseases].
    Calin A.
    Internist (Berl); 1980 Nov; 21(11):697-701. PubMed ID: 7005164
    [No Abstract] [Full Text] [Related]

  • 5. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X, Club Rheumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [Abstract] [Full Text] [Related]

  • 6. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH.
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [Abstract] [Full Text] [Related]

  • 7. Clinical use of immunosuppressive drugs: part I.
    Gerber NL, Steinberg AD.
    Drugs; 1976 Sep; 11(1):14-35. PubMed ID: 770131
    [Abstract] [Full Text] [Related]

  • 8. Medical treatment of connective tissue disease.
    Ciavaglia SJ, Costello PB, Panara N.
    Ear Nose Throat J; 1987 Nov; 66(11):457-62. PubMed ID: 3443075
    [No Abstract] [Full Text] [Related]

  • 9. Immunosuppressive therapy in rheumatic disease.
    Pirofsky B, Bardana EJ.
    Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
    [No Abstract] [Full Text] [Related]

  • 10. [Immunosuppressive therapy in autoimmune diseases].
    Schwarz-Eywill M.
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):93-100. PubMed ID: 10355057
    [Abstract] [Full Text] [Related]

  • 11. Collagen-vascular diseases.
    Rothschild B.
    Prim Care; 1984 Jun; 11(2):307-23. PubMed ID: 6566363
    [Abstract] [Full Text] [Related]

  • 12. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D, DeClerck LS, Bridts CH, Stevens WJ.
    In Vivo; 1994 Jun; 8(4):577-80. PubMed ID: 7534494
    [Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive agents].
    Stüttgen G.
    Arch Dermatol Forsch; 1972 Jun; 244():406-9. PubMed ID: 4405404
    [No Abstract] [Full Text] [Related]

  • 14. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M.
    J Rheumatol Suppl; 1978 Jun; 4():97-100. PubMed ID: 366146
    [Abstract] [Full Text] [Related]

  • 15. [Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].
    Delespesse G, Kennes B, Duchateau J.
    Acta Clin Belg; 1974 Jun; 29(6):413-23. PubMed ID: 4155218
    [No Abstract] [Full Text] [Related]

  • 16. Corticosteroids: Friends and Foes.
    Bolster MB.
    Rheum Dis Clin North Am; 2016 Feb; 42(1):xv-xvi. PubMed ID: 26611560
    [No Abstract] [Full Text] [Related]

  • 17. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y.
    Blood Cells Mol Dis; 2001 Feb; 27(4):750-6. PubMed ID: 11778659
    [Abstract] [Full Text] [Related]

  • 18. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C, Giuggioli D, Raimondo V, L'Andolina M, Tavoni A, Cecchetti R, Guiducci S, Ursini F, Caminiti M, Varcasia G, Gigliotti P, Pellegrini R, Olivo D, Colaci M, Murdaca G, Brittelli R, Mariano GP, Spinella A, Bellando-Randone S, Aiello V, Bilia S, Giannini D, Ferrari T, Caminiti R, Brusi V, Meliconi R, Fallahi P, Antonelli A, COVID-19 & ASD Italian Study Group.
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [Abstract] [Full Text] [Related]

  • 19. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis].
    Ruszczak Z.
    Hautarzt; 1977 Mar; 28(3):125-31. PubMed ID: 15957
    [Abstract] [Full Text] [Related]

  • 20. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L, Szekanecz Z.
    Orv Hetil; 2007 Apr 08; 148 Suppl 1():63-70. PubMed ID: 17430797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.